Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mengxia Yu

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 19, 2017
Chidamide in FLT3-ITD positive acute myeloid leukemia and the synergistic effect in combination with cytarabineXia Li, Xiao Yan, Wenjian Guo, et al.
Oncotarget|April 29, 2017
Homoharringtonine targets Smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cellsJian Chen, Qitian Mu, Xia Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 20, 2015
[Clinical and cytogenetic study of chromosome 1 abnormality in myelodysplastic syndrome]Wei Wang, Zhimei Chen, Mengxia Yu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 27, 2014
[Expression level of SET gene in acute myeloid leukemia and its clinical significance]Peipei Ye, Mengxia Yu, Qitian Mu, et al.
Journal of Cancer Research and Clinical Oncology|February 3, 2018
Promising efficacy of novel BTK inhibitor AC0010 in mantle cell lymphomaXiao Yan, Yile Zhou, Shujuan Huang, et al.
International Journal of Biological Sciences|October 16, 2020
miR-550-1 functions as a tumor suppressor in acute myeloid leukemia via the hippo signaling pathwayChao Hu, Mengxia Yu, Chenying Li, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 10, 2024
High expression of BCAT1 sensitizes AML cells to PARP inhibitor by suppressing DNA damage responseJiajia Pan, Yungui Wang, Shujuan Huang, et al.
Scientific Reports|April 29, 2017
Prognostic significance of huntingtin interacting protein 1 expression on patients with acute myeloid leukemiaJinghan Wang, Mengxia Yu, Qi Guo, et al.
Cancer Letters|July 17, 2019
Abivertinib, a novel BTK inhibitor: Anti-Leukemia effects and synergistic efficacy with homoharringtonine in acute myeloid leukemiaShujuan Huang, Jiajia Pan, Jing Jin, et al.
Oncotarget|July 21, 2016
Prognostic impact of MYH9 expression on patients with acute myeloid leukemiaMengxia Yu, Jinghan Wang, Zhijuan Zhu, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 19, 2017
Chidamide in FLT3-ITD positive acute myeloid leukemia and the synergistic effect in combination with cytarabineXia Li, Xiao Yan, Wenjian Guo, et al.
Oncotarget|April 29, 2017
Homoharringtonine targets Smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cellsJian Chen, Qitian Mu, Xia Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 20, 2015
[Clinical and cytogenetic study of chromosome 1 abnormality in myelodysplastic syndrome]Wei Wang, Zhimei Chen, Mengxia Yu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 27, 2014
[Expression level of SET gene in acute myeloid leukemia and its clinical significance]Peipei Ye, Mengxia Yu, Qitian Mu, et al.
Journal of Cancer Research and Clinical Oncology|February 3, 2018
Promising efficacy of novel BTK inhibitor AC0010 in mantle cell lymphomaXiao Yan, Yile Zhou, Shujuan Huang, et al.
International Journal of Biological Sciences|October 16, 2020
miR-550-1 functions as a tumor suppressor in acute myeloid leukemia via the hippo signaling pathwayChao Hu, Mengxia Yu, Chenying Li, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 10, 2024
High expression of BCAT1 sensitizes AML cells to PARP inhibitor by suppressing DNA damage responseJiajia Pan, Yungui Wang, Shujuan Huang, et al.
Scientific Reports|April 29, 2017
Prognostic significance of huntingtin interacting protein 1 expression on patients with acute myeloid leukemiaJinghan Wang, Mengxia Yu, Qi Guo, et al.
Cancer Letters|July 17, 2019
Abivertinib, a novel BTK inhibitor: Anti-Leukemia effects and synergistic efficacy with homoharringtonine in acute myeloid leukemiaShujuan Huang, Jiajia Pan, Jing Jin, et al.
Oncotarget|July 21, 2016
Prognostic impact of MYH9 expression on patients with acute myeloid leukemiaMengxia Yu, Jinghan Wang, Zhijuan Zhu, et al.
Pageof 7